| |
| |
|
| Insider
Information: |
Lacob Joseph |
| Relationship: |
Director |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,148,647 |
|
|
Indirect Shares
|
598,713 |
|
|
| Direct
Value |
$269,070,093 |
|
|
|
Indirect Value
|
$37,675,559 |
|
|
| Total
Shares |
1,747,360 |
|
|
| Total
Value |
$306,745,652 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 292.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Align Technology Inc |
ALGN |
|
2012-05-21 |
1,044,100 |
2024-05-17 |
133,023 |
Premium* |
|
|
Nuvasive Inc |
NUVA |
Director |
2005-04-29 |
50,942 |
2005-04-29 |
23,211 |
Premium* |
|
|
Ehealth, Inc. |
EHTH |
Director |
2007-11-08 |
26,848 |
2007-11-08 |
18,109 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
Director, 10% Owner |
2007-05-01 |
26,373 |
2007-05-01 |
72,642 |
Premium* |
|
|
Neuropace Inc |
NPCE |
Director |
2022-10-18 |
384 |
2022-10-18 |
351,728 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NPCE |
Neuropace Inc |
Director |
– • – |
2021-04-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,701 |
|
- |
|
| NPCE |
Neuropace Inc |
Director |
– • – |
2021-04-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
192 |
|
- |
|
| NPCE |
Neuropace Inc |
Director |
– • – |
2021-04-26 |
4 |
A |
$0.00 |
$0 |
I/I |
334,027 |
351,920 |
0 |
- |
|
| NPCE |
Neuropace Inc |
Director |
– • – |
2022-10-18 |
4 |
OE |
$0.03 |
$5 |
D/D |
192 |
384 |
0 |
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,090,909 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,250,000 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
664,177 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
988,143 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
376,923 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,298,456 |
2,298,456 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
5,370,152 |
0 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-11-09 |
4 |
D |
$9.41 |
$4,705,000 |
I/I |
(500,000) |
35,211 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-11-09 |
4 |
A |
$9.41 |
$55,594 |
I/I |
5,908 |
5,908 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2004-11-09 |
4 |
A |
$9.41 |
$217,606 |
D/D |
23,125 |
23,125 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2005-04-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(600,000) |
23,211 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2005-04-29 |
4 |
A |
$0.00 |
$0 |
I/I |
3,400 |
9,308 |
|
- |
|
| NUVA |
Nuvasive Inc |
Director |
– • – |
2005-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
27,817 |
50,942 |
|
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2007-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,648,215 |
72,642 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2007-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,373 |
26,373 |
0 |
- |
|
119 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
